Recurrent miscarriage and thrombophilia;Herhaalde miskramen en trombofilie

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 4, 2006, Pages 189-193

  Middeldorp, S ^a   Goddijn, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; HUMAN; LOW DRUG DOSE; RECURRENT ABORTION; REVIEW; SPONTANEOUS ABORTION; THROMBOPHILIA; VEIN THROMBOSIS;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; THROMBOPHILIA;

EID: 32144447488     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:839-54.
2. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update. 2002;8:463-81.
3. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005;83:821-39.
4. Goddijn M, Leschot NL. Genetic aspects of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:855-65.
5. Stirrat GM. Recurrent miscarriage. Lancet. 1990;336:673-5.
6. Goddijn M, Veen F van der, Ankum WM, Bonsel GJ, Leschot NJ, Boer K. Geen eenduidigheid over definitie, diagnostiek en behandeling van habituele abortus in Nederland. Ned Tijdschr Geneeskd. 1999;143:897-902.
7. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod. 1999;14:2868-71.
8. Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Data-base Syst Rev. 2000;(2):CD000112.
9. Oates-Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2003;(4):CD003511.
10. Scott JR, Pattison N. Human chorionic gonadotrophin for recurrent miscarriage. Cochrane Database Syst Rev. 2000;(2):CD000101.
11. n Weitz JI, Middeldorp S, Geerts W, Heit JA. Thrombophilia and new anticoagulant drugs. Hematology (Am Soc Hematol Educ Program). 2004:424-38.
12. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, et al. Antiphospholipid antibodies and venous thromboembolism. Blood. 1995;86:3685-91.
13. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309-11.
14. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516-30.
15. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami, et al. The risk of abortion and stillbirth in antithrombin-protein C-, and protein S-deficient women. Thromb Haemost. 1996;75:387-8.
16. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348:913-6.
17. Meinardi JR, Middeldorp S, Kam PJ de, Koopman MM, Pampus EC van, Hamulyak K, et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation. Ann Intern Med. 1999;130:736-9.
18. Bank I, Libourel EJ, Middeldorp S, Pampus EC van, Koopman MM, Hamulyak K, et al. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med. 2004;164:1932-7.
19. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901-8.
20. Middeldorp S, Poel MH van de, Bank I, Hamulyak K, Libourel EJ, Koopman MM, et al. Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications. Thromb Haemost. 2004;92:787-90.
21. Nelen WL, Blom HJ, Steegers EA, Heijer M den, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000;74:1196-9.
22. Sebire NJ, Regan L, Rai R. Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure. Lupus. 2002;11:641-3.
23. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Chamley L, Vince G. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril. 2005;83:691-8.
24. Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L, et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol. 2005;192:23-30.
25. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314:253-7.
26. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002;100:408-13.
27. Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril. 2005;83:684-90.
28. Empson M, Lassere M, Craig JC, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database SystRev. 2005;(2):CD002859.
29. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004:126(3 Suppl):6278-448.
30. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343:619-29.
31. Bank I, Libourel EJ, Middeldorp S, Meer J van der, Buller HR. High rate of skin complications due to low-molecular-weight heparins in pregnant women. J Thromb Haemost. 2003;1:859-61.
32. Gris JC, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103:3695-9.
33. Di Nisio M, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database SystRev. 2005;(2):CD004734.
34. Middeldorp S. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - no. J Thromb Haemost. 2003;1:2073-4.
35. Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9:331-7.
36. Brenner B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - yes. J Thromb Haemost. 2003;1:2070-2.
37. Walker ID, Kujovich JL, Greer IA, Rey E, David M, Salmon JE, et al. The use of LMWH in pregnancies at risk: new evidence or perception? J Thromb Haemost. 2005;3:778-93.
38. Quenby S, Farquharson RG, Dawood F, Hughes AM, Topping J. Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod. 2005;20:1729-32.
39. Seaman HE, Vries CS de, Farmer RD. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study. Hum Reprod. 2003;18:522-6.
40. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155-60.
41. Krabbendam I, Dekker GA. Pregnancy outcome in patients with a history of recurrent spontaneous miscarriages and documented thrombophilias. Gynecol Obstet Invest. 2004;57:127-31.